Ovary Flashcards
(42 cards)
Follicular Cyst
- Benign cyst measuring at least 3 cm
- If < 3 cm, called cystic follicles
- Lined by an inner layer of granulosa cells
- Outer layer of theca cells
- Formed due to abnormal gonadotrophin stimulation
- Contain clear fluid
Corpus luteum cyst
- Cyst over 3 cm in size
- Inner layer of luteinized granulosa cells
- Outer layer of theca cells
- Corpus luteum is a physiological postovulatory structure formed after the dominant follicle releases the ovum
- Its main purpose is to secrete estrogen and progesterone and it normally regresses at the end of the cycle
- Cystic dilation happens when corpus luteum fails to regress and becomes enlarged with fluid / blood
Hyperreactio luteinalis
- Bilateral, ovarian enlargement due to multiple, luteinized follicle cysts
- Thin-walled cysts
- Rare
- Associated with hydatidiform mole, choriocarcinoma, fetal hydrops due to Rh sensitization and multiple gestations
Micro:
* Follicular cysts with luteinization of theca interna or granulosa cells, edema of theca layer and stroma
Polycystic ovary disease
- Polycystic ovarian syndrome (PCOS) is a clinicopathologic syndrome comprising polycystic ovaries and characteristic clinical features
Clinical:
* Most common cause of anovulatory infertility
* Grossly enlarged, multicystic ovaries
* May not be enlarged in adolescent patients
* Associated with endometrial hyperplasia and endometrial neoplasia
Micro:
* Increased ovarian size, including thickness of cortical and subcortical stroma
* Thickened collagenized tunica
* Normal numbers of primordial follicles
* Twice the expected number of ripening and atretic follicles
* Multiple cystic follicles (1 - 2 mm) with luteinized theca layer (theca lutein hyperplasia)
Endometriosis
- Presence of endometrial tissue outside of endometrium and myometrium, consisting of both endometrial glands and stroma
- Ectopically located endometrial tissue consisting of at least 2 of the following:
- endometrial type glands
- endometrial type stroma or
- evidence of chronic hemorrhage
- Endometriosis is associated with
- Ovarian clear cell carcinoma
- Endometrioid carcinoma
Molecular:
* ARID1A
* PIK3CA
* KRAS
* PPP2R1A
IHC:
* CD10 immunohistochemistry can be used to confirm the presence of endometrial stroma
Neoplastic Lesions of Ovary
Epithelial (~95%)
Type 1
* Low Grade Serous –> KRAS, BRAF
* Endometroid –> KRAS, PIK3CA, PTEN, CTNNB1, ARID1A
* Mucinous –> KRAS, ERBB2, TP53
* Clear Cell –> KRAS, PIK3CA, PTEN, AKT2, ERBB2
Type 2
* High Grade Serous –> TP53, BRCA1/2
* Undifferentiated –> KRAS, HER2
Non-Epithelial (~5%)
- Germ Cell
- Ovarian Sarcoma
- Sex-Cord Stromal
- Small Cell Carcinoma
Pathogenesis:
* Type 1
Progress from benign tumours through borderline tumours
Give rise to low-grade carcinoma
- Type 2
Arise from inclusion cysts/Fallopian tube epithelium
Via intraepithelial precursors that are often not identified
Type 1 vs Type 2 Serous Ovarian Cancers
Type 1
* Progress from Ovarian low malignant potential (LMP) tumors, also known as borderline epithelial ovarian tumors
* Usually low grade
* RAS pathway frequently mutated
* BRCA wild type
* Generally TP53 wild type
* p16 patchy
* Chromosomally stable
* Frequently platinum insensitive
Type 2
* De novo invasive tumours
* High grade
* RAS wild type
* BRCA dysfunction
* TP53 mutant
* P16 block-positive
* Wide spread DNA copy number change
* Usually platinum sensitive
Spectrum of Tubal Epithelial Alterations
Serous tubal intraepithelial carcinoma (STIC)
- Lesion that is limited to the fallopian tube epithelium and a precursor to extrauterine (pelvic) high grade serous carcinoma
Micro:
* Confined to epithelium
* Significant atypia, architectural alterations
* High proliferative index
* Mutant pattern of p53 staining
- Important precursor lesion to recognize, as it is a criterion for assigning fallopian tube as primary site of high grade tubo-ovarian serous carcinoma irrespective of presence and size of ovarian and peritoneal disease
Terminology:
Various terms used to describe a spectrum of tubal epithelial alterations:
**Secretory cell outgrowths (SCOUTs): **
* Secretory cell expansion with variable ciliation
* Type 1 / tubal differentiation
* Type 2 / endometrioid differentiation
* Wild type p53 staining
p53 signature:
* Histologically normal epithelium (at least 12 cells)
* Mutant pattern p53 staining
* Low proliferation index (MIB1) (typically less than 10%)
**Serous tubal intraepithelial lesion (STIL): **
* Abnormal histology (high N/C but preserved polarity)
* Mutant p53
* Variable MIB1
* STIL is regarded as a lesion of uncertain significance and diagnostic features fall short of STIC
Epithelial Ovarian Cancers
High Grade Serous Carcinoma
* 70% all carcinomas
* Precursor: STIC (Fallopian Tube Epithelium)
* Syndromes: BRCA1/2, Hereditary breast and ovarian cancer (HBOC)
* Mutations: TP53, BRCA1/2, HRD, Chromosomal instability, Aneuploidy
* Therapies: PARP inhibitors
Low Grade Serous Carcinoma
* < 5% all carcinomas
* Precursor: Serous borderline tumour (Fallopian Tube Epithelium)
* Syndromes: ??
* Mutations: KRAS, BRAF
* Therapies: MEK1/2 inhibitors
Clear Cell Carcinoma
* <10 % all carcinomas
* Precursor: Clear cell borderline tumour (Endometriosis)
* Syndromes: Lynch syndrome
* Mutations: ARID1A, PIK3CA, CTNNB1, PPP2R1A, MSI
* Therapies: Tyrosine Kinase inhibitors
Endometrioid Carcinoma
* <10 % all carcinomas
* Precursor: Endometrioid borderline tumour (Endometriosis)
* Syndromes: Lynch syndrome
* Mutations: PTEN, ARID1A, CTNNB1, PPP2R1A, MSI
* Therapies: mTOR inhibitors
Mucinous Carcinoma
* <5 % all carcinomas
* Precursor: Mucinous borderline tumour (unknown)
* Syndromes: ?
* Mutations: KRAS, HER2 amplification
* Therapies: Trastuzumab
Serous Cystadenoma/ Adenofibroma
- Benign
- Partially or completely cystic lesion
- Measuring > 1 cm
- Composed of cells resembling fallopian tube epithelium or
- Cuboidal nonciliated epithelium resembling ovarian surface epithelium
Micro:
* Usually small, uni to multilocular cysts
* Lined by a single layer of tall, columnar, ciliated cells resembling normal tubal epithelium or
* Cuboidal nonciliated epithelium resembling ovarian surface epithelium
* Stroma contains spindle fibroblasts
* If papillae are present, they are simple
Adenofibromas and cystadenofibromas
* Composed predominantly of fibrous stroma
* Glands and cysts form a minor component
* If < 10% of the total tumor shows epithelial proliferation within the cysts that would qualify as serous borderline tumor –> designated as serous cystadenoma with focal epithelial proliferation
Serous Borderline Tumour
- Low grade epithelial neoplasm
- Generally younger women with a favorable prognosis when diagnosed at an early stage
- Nonobligate precursor to low grade serous carcinoma (LGSC)
- Can give rise to extra-ovarian abdominoperitoneal or lymph node implants
- Frequently bilateral (up to 33%)
- If peritoneal implants –> risk of recurrence
Macro:
* Complex cystic lesion
* Some delicate papillary excrescences lining inner surface
Micro:
* Non-invasive
* Epithelial proliferation and atypia
* Floating epithelial tufts
* Arbourising papillae –> lined by pseudostratified, cilliated, fallopian tube type epithelium
Molecular:
* KRAS
* BRAF
Implants
- Extraovarian spread is referred to as implants
- Two types:
1) Non-invasive –> Epithelial type, Desmoplastic type
2) Invasive –> LG serous Carcinoma
BRCA
- BRCA 1 and 2 –> very high risk for HGSC
- Often get prophylactic salpingoophorectomy
- BRCA-related cancers have ‘SET’ –> Solid, pseudo-Endometrioid, and Transitional morphology
- Lots of tumour-infiltrating lymphocytes
- Most originate in fallopian tube –> tubal origin until proven otherwise
- Normal tube –> p53 mutation –> STIC –> invasive HGSC –> spreads to ovary
- Rx –> cytotoxic chemotherapy and debulking staging surgery
Mucinous cystadenoma and adenofibroma
- Benign
- Mucinous neoplasm
- Cysts and glands lined by gastrointestinal or Müllerian type mucinous epithelium
- Lacks architectural complexity or cytologic atypia
- May arise from mature teratoma or Brenner tumour
Macro:
* Usually unilateral (95%)
* Smooth or bosselated surface
Cystadenoma:
* Uni or multilocular cyst with variably sized smooth walled locules
* Filled with dense, viscous, sticky, gelatinous material
* No solid areas or papillary excrescences
* Mean size 10 cm, rarely > 30 cm
Adenofibroma:
* Usually smaller
* Predominantly white and solid with variable amounts of small cysts
Molecular:
* KRAS mutations in 68% of cases
Mucinous borderline tumor
- Noninvasive
- Mucinous neoplasm with complex architecture and gastrointestinal type differentiation
Macro:
* > 90% of the tumors are unilateral
* Mean size: 22 cm; some tumors can measure as large as 50 cm
* Cysts are multiloculated with mucinous contents
* Smooth external surface
* Solid areas and necrosis may be present
Micro:
* Complex architecture with tufting and villus formation
* Epithelium resembles low grade dysplasia of the intestine
* Goblet cells, neuroendocrine cells and occasional Paneth cells present
* Neoplastic cells have hyperchromasia, crowding, stratification and mitotic activity
* Glands with luminal mucin
IHC:
CK7
CK20 (variable)
CDX2 (variable) [the extent of expression of CK7 is greater than that of CK20 or CDX2] (Am J Surg Pathol 2006;30:1130)
PAX8 (focal)
SATB2 is positive in a small subset of cases
Mucinous carcinoma
- Unilateral
- Large, complex solid and cystic masses without surface involvement
- 77% of ovarian mucinous carcinomas are metastases
- 23% are ovarian primaries
- Of the ovarian primaries, most arise in a benign or borderline tumor
Two types of invasion -
* Expansile
* Infiltrative –> destructive
- Expansile tumors are usually stage I and behave “benign”
- Infiltrative tumors may demonstrate malignant behavior and cause death even if stage I
Grading:
Not standardized and does not predict prognosis independent of stage.
- Grade 1-no solid areas
- Grade 2-up to 50% solid foci
- Grade 3-more than 50% solid foci
- Severe nuclear atypia can increase raise grade I or II carcinomas by one grade
Molecular:
* KRAS mutations frequent
IHC:
CEA
CK7
CK20
CA125 (weak)
Ovarian mucinous tumours - Primary vs Mets
Primary
* Unilateral»_space;> Bilateral
* Often >10cm
* Usually expansile growth pattern
* No LVI
* No surface involvement
* No hilar involvement
* May have associated teratomas, Brenner tumours, mural nodules
* Rarely associated with pseudomyxoma peritoneii
* SATB usually negative, SMADA4 retained
Metastasis
* Bilateral > Unilateral
* Rarely >10cm
* Usually infiltrative growth pattern
* Often LVI
* Often surface involvement + acellular mucin
* Hilar involvement often present
* Associated ovarian pathology usually absent
* SATB2 usually positive in GI mets, SMADA4 may be lost
Common sites of involvement
* Appendix
* Pancreas
* Colon
* Gallbladder
* Stomach
* Cervix
Mural Nodules
- Grossly circumscribed nodules
- Most associated with primary ovarian mucinous neoplasms (less frequently other ovarian tumor types)
- May be microscopically invasive but still separate / distinct from the associated mucinous tumor
- Associated mucinous tumor may be benign, borderline or malignant
- Reactive and malignant can be hard to tell apart
Types:
* Reactive (sarcoma-like)
* Benign neoplastic (leiomyomatous)
* Malignant (anaplastic carcinoma, sarcoma, carcinosarcoma)
Endometrioid carcinoma of the Ovary
- Ovarian carcinoma resembling endometrioid adenocarcinoma of the endometrium
- Usually low grade and diagnosed at early stages
- May be associated with endometriosis and adenofibroma
- Stage is the most important prognostic factor
Macro:
* Usually unilateral; only 5% bilateral
* Cystic with solid component and areas of hemorrhage
Micro:
* Most common –> confluent (back to back) glands
* Stromal invasion usually by expansion
* Rarely, destructive stromal invasion can be observed
* Squamous metaplasia (morules or keratin pearls) can be seen
Histologic grading:
* Same as for endometrial endometrioid adenocarcinoma
- FIGO grade 1: less than 5% solid component
- FIGO grade 2: 6 - 50% solid component
- FIGO grade 3: more than 50% solid component
IHC:
* Keratin cocktails
* EMA
* CK7
* PAX8 (15% negative)
* ER and PR
* p53: wild / normal type expression (most tumors), high grade endometrioid cancers might demonstrate mutational pattern
* Mismatch repair protein deficiency has been reported in up to 23% of tumors
Clear cell carcinoma of the Ovary
- Malignant epithelial tumor
- Usually unilateral
- Solid to cystic
- May be associated with endometriosis or Lynch syndrome
- Stage is the most important prognostic factor
Micro:
* Clear, eosinophilic or hobnail cells
* 3 classic growth patterns, frequently admixed but 1 pattern may predominate
Papillary:
* Most frequent (70%)
* Usually small, round, simple, nonbranching papillae with fibrous / hyalinized, edematous / myxoid or empty (open tumor rings) stromal cores
* Lined by 1 - 2 layers of cuboidal, flattened or hobnail cells
* Micropapillary tufts may be seen
Tubulocystic:
* Frequent (65%)
* Variably sized tubules and cysts, with or without intraluminal dense eosinophilic secretions and outpouchings
* Lined by a single layer of hobnail, cuboidal or flattened cells
* Often associated with an adenofibromatous background
Solid:
* Least common (62%)
* Diffuse sheets or nested clusters of polyhedral cells separated by delicate septa exhibiting clear to eosinophilic cytoplasm
Molecular:
* ARID1A
* PIK3CA
IHC:
* CK7 +
* HNF-1B +
* Napsin A +
* PAS + –> glycogen rich cytoplasm
* ER/PR -
* WT1-
Brenner tumors
- Tumor composed of transitional / urothelial-like epithelium, typically embedded in fibromatous stroma
- Benign, borderline and malignant variants are recognized, based on the growth pattern and cytological features of the epithelial cells
- Cell of origin of Brenner tumors is controversial; they may arise from Walthard rests
- No atypia
- No increased mitotic activity
Micro:
Benign Brenner tumor:
* Nests of bland transitional epithelium present within fibromatous stroma
Borderline Brenner tumor:
* Papillary architecture with papillae covered by multilayered transitional epithelium
* There is variable but usually low grade cytological atypia
Malignant Brenner tumor:
* Stromal invasion by carcinoma with transitional cell features
* Associated with a benign or borderline Brenner tumor
IHC:
* p63
* GATA3
* CK7
* Uroplakin
* Thrombomodulin
* EMA
* CEA
Walthard cell nests
- Nests, plaques or cysts (with eosinophilic luminal material)
- Metaplastic transitional epithelium involving the serosal surface of fallopian tube, mesosalpinx and mesovarium
- Benign common incidental finding
- Bland transitional type epithelium forming small nests / cysts
Micro:
* Small solid nests or cysts of transitional type epithelium
* Relatively uniform nuclei with irregular borders and nuclear grooves, located beneath the serosa of tubal / paratubal / paraovarian tissue
* Cystic lesions may have eosinophilic luminal secretions
* Rare or no mitotic figures
IHC:
* p63
* GATA3
* CK7
Negative:
* PAX8
* CK20
* Uroplakin
* SALL4
Pathogenesis:
Early events:
* Activating PIK3CA mutations (27%)
* CDKN2A loss (55%)
Two different pathways, Late events:
* FGFR3 alterations (45%)
* MDM2/TP53 alterations (46%)
Ovarian Cancer Genetics
Sporadic:
* 85-90%
Hereditary:
* 10-15%
* 80-90% –> BRCA1 and 2, RAD51c and RAD51D –> Hereditary Breast and Ovarian Cancer Syndrome
* Further syndromes –> Lynch, Li-Fraumeni, Cowden, Gorlin, Peutz-Jeghers
Hereditary Breast and Ovarian Cancer Syndrome:
* BRCA1
* BRCA2
* Breast, Ovary, Melanoma, Prostate, Pancreatic Ca
Hereditary Breast and Ovarian Cancer Syndrome:
* RAD51C
* RAD51D
* BRIP1
* Ovary Ca
Lynch Syndrome:
* MLH1
* MSH2
* MSH6
* PMS2
* EPCAM
* Uterine, Colon, Ovary, Pancreatic, Gastric, Small Bowel, CNS, Renal, Sebaceous
Cowden Syndrome:
* PTEN
* Breast, Uterine, Thyroid, Colon, Renal, Sebaceous
Li-Fraumeni:
* p53
* Sarcomas, Breast, Adrenal, Brain, Lung, Endometrial
Peutz-Jegers:
* STK11
* GI, Breast, Ovarian, Sex cord stromal, Uterine, Cervical
Gorlin-Goltz Syndrome:
* Autosomal dominant
* PTCH1 –> Chromosome 9
* Dental/Ossesum anomalies
* Cutaneous anomalies –> BCC, dermal cysts
* Opthalmic –> Hypertelorism strabismus
* Neurological –> retardationm, calcification of falx cerebri
* Sexual anomalies –> Hypogonadism, Ovarian tumour
Ovarian Sex Cord Stromal Tumours
Pure Stromal Tumours:
* Fibroma
* Thecoma
* Steroid Cell
* Leydig Cell
* Sclerosing Stromal
Pure Sex Cord Tumours:
* Adult Granulosa Cell
* Juvenile Granulosa Cell
* Sex Cord Tumour with Annular Tubules
Mixed Sex Cord-Stromal Tumours:
* Sertoli-Leydig Cell
Hormone Producing Ovarian Tumours:
Oestrogen Producing:
* Granulosa Cell
* Thecoma
Androgen Producing:
* Steroid Cell
* Sertoli-Leydig Cell
* Leydig Cell
IHC:
* Either +ve or -ve for CK
* Almost always EMA -ve
* +ve EMA suggests epithelial mimic
* Inhibin –> Relatively specific marker
* Calretinin –> More sensitive, less specific
* CD56 –> cytoplasmic and membranous
* WT1 –> Nuclear
* SF-1